Rethinking Diabetes: A Weekly Review
Malattie Metaboliche e Diabetologia
Diabetes Management and Complications: Latest Research Insights
This episode explores the latest research on diabetes complications and management, covering retinopathy progression, laboratory guidelines, closed-loop systems, microvascular complications, foot ulcers, gut microbiota, environmental factors, metformin's effects, bariatric surgery outcomes, and pharmacotherapy comparisons.
Bibliography
1. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Authors: Perais J, Agarwal R, Evans JR, et al.
Journal: The Cochrane database of systematic reviews, 2023 Feb 22
PMID: 36815723
DOI: 10.1002/14651858.CD013775.pub2
2. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
Authors: Sacks DB, Arnold M, Bakris GL, et al.
Journal: Diabetes care, 2023 Oct 1
PMID: 37471273
DOI: 10.2337/dci23-0036
3. Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.
Authors: Asgharzadeh A, Patel M, Connock M, et al.
Journal: Health technology assessment (Winchester, England), 2024 Dec
PMID: 39673446
DOI: 10.3310/JYPL3536
4. Prevention of Microvascular Complications of Diabetes.
Authors: Crasto W, Patel V, Davies MJ, et al.
Journal: Endocrinology and metabolism clinics of North America, 2021 Sep
PMID: 34399955
DOI: 10.1016/j.ecl.2021.05.005
5. Mechanisms of diabetic foot ulceration: A review.
Authors: Deng H, Li B, Shen Q, et al.
Journal: Journal of diabetes, 2023 Apr
PMID: 36891783
DOI: 10.1111/1753-0407.13372
6. Gut microbiota and the early prevention window in type 1 diabetes and latent autoimmune diabetes in adults: a state-of-the-art narrative review on diet and metabolites.
Authors: Kaminska H, Wieczorek W, Pruc M, et al.
Journal: Frontiers in endocrinology, 2026
PMID: 42181191
DOI: 10.3389/fendo.2026.1837746
7. Do We Have Enough Evidence That Metformin Is Superior to Other Antidiabetic Drugs in Pancreatic Cancer Risk Reduction?
Authors: Szymczak-Pajor I, Drzewoski J, Wenclewska S, et al.
Journal: International journal of molecular sciences, 2026 May 8
PMID: 42196179
DOI: 10.3390/ijms27104195
8. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.
Authors: Salminen P, Grönroos S, Helmiö M, et al.
Journal: JAMA surgery, 2022 Aug 1
PMID: 35731535
DOI: 10.1001/jamasurg.2022.2229
9. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
Authors: Palmer SC, Tendal B, Mustafa RA, et al.
Journal: BMJ (Clinical research ed.), 2021 Jan 13
PMID: 33441402
DOI: 10.1136/bmj.m4573
10. Decoding the exposome for type 1 diabetes prevention: A scoping review of environmental determinants.
Authors: Rollet M, Aguayo GA, Canha D, et al.
Journal: Diabetes & metabolism, 2026 May
PMID: 41905461
DOI: 10.1016/j.diabet.2026.101756
Authors: Perais J, Agarwal R, Evans JR, et al.
Journal: The Cochrane database of systematic reviews, 2023 Feb 22
PMID: 36815723
DOI: 10.1002/14651858.CD013775.pub2
2. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
Authors: Sacks DB, Arnold M, Bakris GL, et al.
Journal: Diabetes care, 2023 Oct 1
PMID: 37471273
DOI: 10.2337/dci23-0036
3. Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.
Authors: Asgharzadeh A, Patel M, Connock M, et al.
Journal: Health technology assessment (Winchester, England), 2024 Dec
PMID: 39673446
DOI: 10.3310/JYPL3536
4. Prevention of Microvascular Complications of Diabetes.
Authors: Crasto W, Patel V, Davies MJ, et al.
Journal: Endocrinology and metabolism clinics of North America, 2021 Sep
PMID: 34399955
DOI: 10.1016/j.ecl.2021.05.005
5. Mechanisms of diabetic foot ulceration: A review.
Authors: Deng H, Li B, Shen Q, et al.
Journal: Journal of diabetes, 2023 Apr
PMID: 36891783
DOI: 10.1111/1753-0407.13372
6. Gut microbiota and the early prevention window in type 1 diabetes and latent autoimmune diabetes in adults: a state-of-the-art narrative review on diet and metabolites.
Authors: Kaminska H, Wieczorek W, Pruc M, et al.
Journal: Frontiers in endocrinology, 2026
PMID: 42181191
DOI: 10.3389/fendo.2026.1837746
7. Do We Have Enough Evidence That Metformin Is Superior to Other Antidiabetic Drugs in Pancreatic Cancer Risk Reduction?
Authors: Szymczak-Pajor I, Drzewoski J, Wenclewska S, et al.
Journal: International journal of molecular sciences, 2026 May 8
PMID: 42196179
DOI: 10.3390/ijms27104195
8. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.
Authors: Salminen P, Grönroos S, Helmiö M, et al.
Journal: JAMA surgery, 2022 Aug 1
PMID: 35731535
DOI: 10.1001/jamasurg.2022.2229
9. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
Authors: Palmer SC, Tendal B, Mustafa RA, et al.
Journal: BMJ (Clinical research ed.), 2021 Jan 13
PMID: 33441402
DOI: 10.1136/bmj.m4573
10. Decoding the exposome for type 1 diabetes prevention: A scoping review of environmental determinants.
Authors: Rollet M, Aguayo GA, Canha D, et al.
Journal: Diabetes & metabolism, 2026 May
PMID: 41905461
DOI: 10.1016/j.diabet.2026.101756
